TGA accepts Lawley product for evaluation in postmenopausal women with HSDD. Banner

Category: low libido in women

TGA accepts Lawley product for evaluation in postmenopausal women with HSDD.

TGA accepts Lawley product for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals Pty Ltd today announced… Continue Reading →

Read more

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal… Continue Reading →

Read more

Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address

  In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →

Read more

BBC Menopause and testosterone replacement therapy

Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous… Continue Reading →

Read more

Effects of testosterone therapy in women – new systematic review and meta-analysis

It has been over a decade since the last systematic review and meta-analysis on the effects of testosterone for women was conducted as an… Continue Reading →

Read more

Hypoactive Sexual Desire Disorder (HSDD) re-defined

In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created… Continue Reading →

Read more

FDA acknowledges there is a medical need for treating female sexual dysfunction

In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment.  This document states ”… Continue Reading →

Read more

EDUCATION: View presentations on testosterone management in men and women

EDUCATION View presentations on testosterone management in men and women In June 2017 the Lawley website added a ‘Health Professional Section’. This password protected learning area will… Continue Reading →

Read more
FDA releases Industry Guidance for Low Sexual Interest, Desire and/or Arousal in Women thumbnail
Categories:

FDA releases Industry Guidance for Low Sexual Interest, Desire and/or Arousal in Women

In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment. … Continue Reading →

Read more

Flibanserin, the drug that gives women one extra sexually satisfying experience every two months

Flibanserin, the drug that gives women one extra sexually satisfying experience every two months

Read more